Catherine Coste - 18 Mar 2025 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Director
Signature
/s/ Catherine Coste
Issuer symbol
BLFS
Transactions as of
18 Mar 2025
Transactions value $
$0
Form type
4
Filing time
20 Mar 2025, 19:09:27 UTC
Previous filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Award +5.7K 5.7K 18 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the measurement date of 01-02-2025.